Black Rock Inc. Royalty Pharma PLC Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
A detailed history of Black Rock Inc. transactions in Royalty Pharma PLC stock. As of the latest transaction made, Black Rock Inc. holds 23,017,561 shares of RPRX stock, worth $589 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
23,017,561
Previous 21,205,841
8.54%
Holding current value
$589 Million
Previous $644 Million
5.75%
% of portfolio
0.01%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding RPRX
# of Institutions
410Shares Held
284MCall Options Held
499KPut Options Held
47.5K-
Morgan Stanley New York, NY41.1MShares$1.05 Billion0.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA37.6MShares$961 Million0.02% of portfolio
-
Baillie Gifford & CO16.1MShares$412 Million0.35% of portfolio
-
Viking Global Investors LP12.1MShares$309 Million1.32% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA11.9MShares$304 Million0.62% of portfolio
About Royalty Pharma plc
- Ticker RPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 437,139,008
- Market Cap $11.2B
- Description
- Royalty Pharma plc operates as a buyer of biopharmaceutical royalties and a funder of innovations in the biopharmaceutical industry in the United States. It is also involved in the identification, evaluation, and acquisition of royalties on various biopharmaceutical therapies. In addition, the company collaborates with innovators from academic i...